Kim Kyeong Min, Oh Hyung Jung, Choi Hyung Yun, Lee Hajeong, Ryu Dong-Ryeol
ESRD Registry Committee, Korean Society of Nephrology, Seoul, Korea.
Department of Internal Medicine, Eulji University Hospital, College of Medicine, Eulji University, Daejeon, Korea.
Kidney Res Clin Pract. 2019 Sep 30;38(3):382-390. doi: 10.23876/j.krcp.18.0128.
Mortality is higher in patients with chronic kidney disease (CKD) than in the general population, but little information is available on CKD-related mortality that is representative of the Korean population. Our objective was to investigate mortality risk in Korean patients with CKD.
We identified patients with incident CKD who had not undergone dialysis or kidney transplantation between January 1, 2003 and December 31, 2007 in Korea using the database of the Korean National Health Insurance Service-National Sample Cohort, and stratified the population into the following three groups: group 1 (n = 1,473), controls; group 2 (n = 2,212), patients with diabetes or hypertension, but without CKD; and group 3 (n = 2,212), patients with CKD. We then monitored them for all-cause mortality until December 2013.
A total of 1,473 patients were included in this analysis. During the follow-up period, 941 patients in group 3 died (134 deaths/1,000 person-years) compared with 550 deaths in the group 2 (34 deaths/1,000 person-years) and 459 deaths in group 1 (30 deaths/1,000 person-years). The rate ratio for mortality rate was 4.5, and the hazard ratio for mortality was 4.88 (95% confidence interval [CI], 4.36-5.47, < 0.001) in patients in group 3 compared with age- and sex-matched controls (group 1). The rate ratio for mortality rate was 4.0, and the hazard ratio for mortality was 4.36 (95% CI, 3.92-4.85, < 0.001) in patients in group 3 compared with patients in group 2.
In this nationally representative sample cohort, excess mortality was observed in Korean patients with incident CKD.
慢性肾脏病(CKD)患者的死亡率高于普通人群,但关于代表韩国人群的CKD相关死亡率的信息却很少。我们的目的是调查韩国CKD患者的死亡风险。
我们使用韩国国民健康保险服务-全国样本队列数据库,确定了2003年1月1日至2007年12月31日期间在韩国未接受透析或肾移植的初发CKD患者,并将人群分为以下三组:第1组(n = 1473),对照组;第2组(n = 2212),患有糖尿病或高血压但无CKD的患者;第3组(n = 2212),CKD患者。然后对他们进行全因死亡率监测,直至2013年12月。
本分析共纳入1473例患者。在随访期间,第3组有941例患者死亡(134例死亡/1000人年),而第2组有550例死亡(34例死亡/1000人年),第1组有459例死亡(30例死亡/1000人年)。与年龄和性别匹配的对照组(第1组)相比,第3组患者的死亡率比值为4.5,死亡风险比为4.88(95%置信区间[CI],4.36 - 5.47,P < 0.001)。与第2组患者相比,第3组患者的死亡率比值为4.0,死亡风险比为4.36(95% CI,3.92 - 4.85,P < 0.001)。
在这个具有全国代表性的样本队列中,观察到韩国初发CKD患者存在超额死亡率。